ENDPOINTS

FDA to biotech CEOs: US is lagging behind on early-stage trials

Top FDA officials sided with biotech CEOs this week on the need to speed up FDA reviews to stay competitive with China and other countries, in the latest agency "listening" session with industry. Competition with ...

Jun 20, 2025 - 19:20
 0
FDA to biotech CEOs: US is lagging behind on early-stage trials
Top FDA officials sided with biotech CEOs this week on the need to speed up FDA reviews to stay competitive with China and other countries, in the latest agency "listening" session with industry. Competition with ...
Read More

Tags:

Previous Article

Thirdhand smoke is a ‘silent threat’ to kids

Next Article

Supreme Court Rules Fuel Producers Can Challenge California’s Limits on Car Emis...

Related Posts

Big pharma companies explain why tariffs will harm US investments 

Big pharma companies explain why tariffs will harm US i...

May 29, 2025  0

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

FDA rejects Stealth's rare disease drug, but offers pot...

May 29, 2025  0

Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M

Lilly pledges more than $650M to muscle health biotech;...

Jun 11, 2025  0